TLDR Loose Anagen Syndrome causes easy-to-pull, thin hair, mainly in young girls, and improves with age.
The document from 1996 describes Loose Anagen Syndrome, a condition more common in young girls, where anagen hairs can be easily plucked due to a lack of root sheaths. It often leads to sparse, thin, and patchy hair without scarring or inflammation. Diagnosis involves examining plucked hairs, which show anagen phase hairs with poor attachment to the shaft. The condition may be hereditary with an autosomal dominant pattern and is thought to be caused by abnormal keratinization or alterations in cell adhesion molecules. While it tends to improve after adolescence, there is no specific treatment except for gentle hair handling. Further research is needed to understand the underlying mechanisms of the syndrome.
19 citations,
April 1995 in “Clinical Genetics” Two siblings were the first reported cases of inheriting both eye coloboma and loose anagen syndrome together.
130 citations,
January 1994 in “Differentiation” Mouse hair follicle cells briefly grow during the early hair growth phase, showing that these cells are important for starting the hair cycle.
35 citations,
January 1993 in “International Journal of Dermatology” People with HIV and low T cell counts have more hair and scalp problems.
55 citations,
October 1992 in “Archives of Dermatology” Loose Anagen Hair Syndrome is a hereditary condition causing hair loss in children due to abnormal hair follicles.
85 citations,
February 1989 in “Journal of The American Academy of Dermatology” Children with loose anagen hair have easily pluckable hair due to root sheath problems, and it might improve without treatment.
17 citations,
August 1979 in “Journal of The American Academy of Dermatology” A new staining method helps tell growing from resting hairs to diagnose hair loss.
April 2019 in “International journal of research in dermatology” A child with rough nails also had hair loss and allergies.
37 citations,
October 2017 in “Clinical and Experimental Dermatology” Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.
18 citations,
January 2010 in “Dermatology Research and Practice” DPCP treatment for alopecia areata can sometimes cause vitiligo.